Recombinant Anti-DLL4 × Anti-VEGF Bispecific Antibody (Bi-sdAb, A1) (CAT#: NANO-MZ001)
This bispecific binding molecule is useful as pharmacologically active agents in compositions in the prevention, treatment, alleviation and diagnosis of diseases or conditions that can be modulated by inhibition of DII4, such as cancer. It is also capable of blocking DLL4 and VEGF activation as well as inhibiting the VEGF induced Erk phosphoryaltion.
Specific Inquiry
Specifications
- Target
- DLL4 & VEGF
- Type
- Bi-sdAb
- Species Reactivity
- Human
- Target 1
- DLL4 (Delta like ligand 4)
- Host Species 1
- Llama
- Target 2
- VEGF
- Host Species 2
- Llama
- Application
- ELISA
- Related Disease
- Human colon cancer
Target
- Target 1
- DLL4 (Delta like ligand 4)
- Gene ID
- 54567
- UniProt ID
- Q9NR61
- Alternative Names
- DLL4; delta-like 4 (Drosophila); hdelta2; delta-like protein 4; delta4; delta 4; delta ligand 4; notch ligand DLL4; delta-like 4 homolog; delta-like 4 protein; notch ligand delta-2; drosophila Delta homolog 4
- Target 2
- VEGF
- Alternative Names
- VEGF; Vascular endothelial growth factor
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for NANO-MZ001. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.